Anxiety and Depression Raise the Risk for Long COVID

May 24, 2022
A new 23andMe study found that a history of depression or anxiety was associated with more than a two-fold increase in the risk of being diagnosed with Long COVID. The study, among the largest done to date on long COVID, also found the women were more than twice as likely to be diagnosed with long COVID, and that being vaccinated has a a modest impact on resolving symptoms for about 20 percent of those with long COVID but has no effect for about half of those with the condition.
Read More

Postdoc Opportunities at 23andMe

May 06, 2022
If you’re a recent Ph.D. graduate interested in opportunities to work with genetic data in the search for new insights into human disease and new treatments for those conditions, then...
Read More

23andMe Launches Sarcoidosis Study

April 30, 2022
Diseases are considered rare if they affect fewer than 200,000 in the United States, but collectively rare diseases — there are nearly 7,000 — are more common than we realize,...
Read More

Improving Screening for Type 2 Diabetes

April 14, 2022
The numbers are staggering.  In the last two decades, the number of Americans with Type 2 diabetes has reached epidemic proportions. More than a third of adults in the United...
Read More

A First Glimpse of a New Cohort to Study Depression and Bipolar Disorder

April 06, 2022
A 23andMe study published this month provides insight into the cause and overlapping genetics of two mental health disorders – depression and bipolar disorder.  The National Institutes of Health estimates that...
Read More

New Study on Genetics of Educational Attainment

March 31, 2022
Using data from more than 3 million people, a team of researchers from the Social Science Genetic Association Consortium completed what is now the largest genetic study ever done on...
Read More

Introducing the New Lead Scientist for Parkinson’s Research at 23andMe

March 21, 2022
Our bodies do a lot on autopilot — breathing, keeping our hearts going, sweating, digesting our food. But sometimes those automatic functions don’t work automatically.  So-called “autonomic dysfunction” is when...
Read More

23andMe’s Drug Discovery Process Explained

February 10, 2022
23andMe's vice president for human genetics, Adam Auton, explains how our unique database shapes our approach to drug discovery. It begins with human genetics, but it doesn't end there. 
Read More

Consumer Genetic Testing Helps People at Risk for Hard to Diagnose Condition

January 28, 2022
23andMe researchers found that direct-to-consumer DNA testing can help identify individuals who are at risk for the hard-to-diagnose genetic condition alpha-1 antitrypsin deficiency (AATD), a condition that increases the risk of lung and liver disease. 
Read More

23andMe Study on Loss of Smell and Taste Due to COVID-19 Published

January 17, 2022
23andMe’s research that has identified genetic variants associated with the loss of smell or taste due to COVID-19 was published today in the journal Nature Genetics. As part of 23andMe’s ongoing...
Read More